Sage Journals: Discover world-class research

Retricted access

Other

First published 2010-12

The impact of liquidity and transaction costs on the 52-week high momentum strategy in Australia

Jenni L. Bettman, Stephen J. Sault, Anna H. von Reibnitz

Australian Journal of Management

Open access

Research article

First published 2017

Impact of Elosulfase Alfa on Pain in Patients with Morquio A Syndrome over 52 Weeks

Marsha Treadwell, Paul R. Harmatz, Barbara K. Burton [...]

Journal of Inborn Errors of Metabolism and Screening

Open access

Research article

First published 2024-10

Association of Self-Reported Improvement After 4 Weeks and Outcomes After 52 Weeks Among Adolescents With Patellofemoral Pain and Osgood-Schlatter Disease

Michael Skovdal Rathleff, Kristian Thorborg, Alessandro Andreucci [...]

Orthopaedic Journal of Sports Medicine

Retricted access

Other

First published 1998-3

The Effect of Atorvastatin on the Human Lens After 52 Weeks of Treatment

Leon Reid, Rebecca Bakker-Arkema, Donald Black

Journal of Cardiovascular Pharmacology and Therapeutics

Retricted access

Research article

First published 2026

Tralokinumab for Chronic Hand Eczema: A 52 Week Observational Case Series

Daniel Blaya Imbernón, Malena Finello, Rodrigo Peñuelas Leal [...]

Journal of Cutaneous Medicine and Surgery

Open access

Research article

First published 2018

UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation

Yan Yiannakou, Anu Agrawal, Patrick B. Allen [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2023-12

Cross-resistance to entry inhibitors and lenacapavir resistance through Week 52 in study CAPELLA

Nicolas Margot, Nina Pennetzdorfer, Vidula Naik [...]

Antiviral Therapy

Retricted access

Research article

First published 2021-1

Anchoring in Mergers and Acquisitions: Does the Regulatory Environment Matter?

Kavitha Ranganathan, Poonam Singh

Journal of Accounting,Auditing & Finance

Open access

Research article

First published 2021

Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study

Carl Eriksson, Sara Rundquist, Vyron Lykiardopoulos [...]

Therapeutic Advances in Gastroenterology

Retricted access

Research article

First published 2016-12

A 52-Week Study of Olanzapine with a Randomized Behavioral Weight Counseling Intervention in Adolescents with Schizophrenia or Bipolar I Disorder

Holland C. Detke, Melissa P. DelBello, John Landry [...]

Journal of Child and Adolescent Psychopharmacology

Search results